JPRN-UMIN000050930
Recruiting
未知
A multicenter observational study using multigene assays (MammaPrint/BluePrint) to assess the risk of early recurrence in hormone receptor-positive, HER2-negative early breast cancer(WJOG16722B) - RealisE-TR
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Hormone receptor positive and HER2 negative early breast cancer
- Sponsor
- West Japan Oncology Group
- Enrollment
- 120
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Polatuzumab vedotin plus R-CHP therapy in patients with previously untreated diffuse large B-cell lymphomaDiffuse large B-cell lymphomDLBCLDLBCJPRN-jRCT1071220082Kato Koji500
Recruiting
Not Applicable
The study on prognosis in patients with fatty liverJPRN-UMIN000046497Yokohama City University3,000
Completed
Not Applicable
A multicenter, prospective, observational study for the association serum pancreatic enzyme level and CT image findings in post-ERCP pancreatitisPost-ERCP pancreatitisJPRN-UMIN000024814Department of Gastroenterology, Kyoto Second Red Cross Hospital5,000
Completed
Not Applicable
A multicenter, prospective, observational study for the incidence and high risk factor of post-ERCP pancreatitisPost-ERCP pancreatitisJPRN-UMIN000024813Department of Gastroenterology, Kyoto Second Red Cross Hospital5,000
Recruiting
Not Applicable
A multicenter, prospective, observational study for the control of delayed chemotherapy-induced nausea and vomiting for upper gastrointestinal cancerJPRN-UMIN000052322agoya University135